Colleen McCormick, MD
Obstetrics & Gynecology · Baltimore, MDNPI 1740362052
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,325 of the $28,735 with a category attached, or 81.2%. 11 manufacturers reported payments, led by GSK at 55.8% of the total. Reporting peaked in 2019 at $9,789 and has fallen 98.7% since, to $124 in 2025. Among obstetrics & gynecology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $586.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$16K
- AstraZeneca$9K
- Clovis Oncology, Inc.$2K
- Tesaro, Inc.$508
- Merck$333
- Genmab U.S., Inc.$247
- plus $401 from 5 others
Across 94 payments — averaging $19,486 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.2M
- Alkermes, Inc.$276K
- Astrazeneca UK Limited$122K
- Clovis Oncology, Inc.$117K
- AstraZeneca$77K
- GSK$36K
- plus $42K from 4 others
What the payments were for
- Consulting fees$23,32581%
- Speaking & faculty fees$2,80010%
- Travel & lodging$6152%
- Food & beverage$1,9847%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 8 | $16,025 |
| AstraZeneca | 16 | $9,472 |
| Clovis Oncology, Inc. | 1 | $1,750 |
| Tesaro, Inc. | 6 | $508 |
| Merck | 8 | $333 |
| Genmab U.S., Inc. | 2 | $247 |
| Johnson & Johnson | 4 | $132 |
| Foundation Medicine, Inc. | 1 | $117 |
| Medical Device Business Services, Inc. | 1 | $87 |
| Seagen Inc. | 1 | $36 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$9,618
- LYNPARZA$9,178
- JEMPERLI$3,200
- Rubraca$1,750
- TIVDAK$247
- KEYTRUDA$134
- FOUNDATIONONE$117
- FOUNDATIONONE HEME$117
- FOUNDATIONONE CDX$117
- FOUNDATIONFOCUS$117
- FOUNDATIONONE LIQUID$117
How this compares
$28,735 in reported general payments places this provider in the 95th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Baltimore
- Danielle ShillerBaltimore$221K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Christina EnzmannBaltimore$63K
- Latasha MurphyBaltimore$41K
- Ishrat RafiBaltimore$29K
- Jenell ColemanBaltimore$18K
- David MatthewsBaltimore$12K
- Anne BurkeBaltimore$12K
- Michelle KushBaltimore$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.